Systems and methods for virtual contrast agent simulation and computational fluid dynamics (CFD) to compute functional significance of stenoses
Systems and methods are disclosed for assessing a risk of disease. One method includes obtaining an anatomic model associated with a target anatomy; modeling, using a processor, an injection of one or more virtual contrast agents into the anatomic model; performing a simulation of flow of blood and the one or more virtual contrast agents through the anatomic model; and computing one or more characteristics of concentration associated with the one or more virtual contrast agents at one or more locations in the anatomic model based on the simulation.
1. A computer-implemented method of assessing a risk of disease, the method comprising:
obtaining an anatomic model of a patient's vasculature;
determining a location of the anatomic model associated with a narrowing of the patient's vasculature;
determining a first point of interest upstream of the location associated with the narrowing of the patient's vasculature;
receiving a value of concentration of one or more virtual contrast agents at the determined first point of interest;
determining a density of the patient's blood and a density of the one or more virtual contrast agents;
determining a two-phase system for modeling the flow of the one or more virtual contrast agents and the patient's blood using the determined density of the patient's blood and determined density of the one or more virtual contrast agents;
modeling, using a processor, an injection of the one or more virtual contrast agents into the anatomic model using the two-phase system;
determining a second point of interest downstream of the location associated with the narrowing of the patient's vasculature;
computing, based on the modeling, a value of concentration of the one or more virtual contrast agents at the determined second point of interest; and
determining one or more diagnostic flow metrics by comparing the received value of concentration at the determined first point of interest to the computed value of concentration at the determined second point of interest.
2. The method of claim 1 , wherein the one or more diagnostic flow metrics include a transluminal attenuation gradient, a corrected coronary opacification, a corrected thrombolysis in myocardial infarction frame count, a thrombolysis in myocardial infarction myocardial perfusion grade, or a combination thereof.
3. The method of claim 1 , further including:
determining a threshold score, wherein the threshold score is associated with a risk of disease; and
comparing the one or more determined diagnostic flow metrics against the threshold score.
4. The method of claim 3 , further including:
outputting a diagnosis for the disease, a diagnosis probability for the disease, or a combination thereof based on the comparison.
5. The method of claim 3 , further including:
determining a primary metric of a blood flow characteristic; and
outputting a diagnosis for the disease, a diagnosis probability for the disease, or a combination thereof based on the primary metric and the comparison.
6. The method of claim 5 , wherein the primary metric is fractional flow reserve.
7. The method of claim 1 , further including:
identifying one or more segments of the anatomic model, wherein each of the one or more determined diagnostic flow metrics are respective of one of the one or more segments.
8. The method of claim 1 , wherein the one or more determined diagnostic flow metrics are representative of a functional significance of stenoses in blood vessels.
9. A system for assessing a risk of heart disease, the system comprising:
a data storage device storing instructions for assessing risk of disease; and
a processor configured to execute the instructions to perform a method including:
obtaining an anatomic model of a patient's vasculature;
determining a location of the anatomic model associated with a narrowing of the patient's vasculature;
determining a first point of interest upstream of the location associated with the narrowing of the patient's vasculature;
receiving a value of concentration of one or more virtual contrast agents at the determined first point of interest;
determining a density of the patient's blood and a density of the one or more virtual contrast agents;
determining a two-phase system for modeling the flow of the one or more virtual contrast agents and the patient's blood using the determined density of the patient's blood and determined density of the one or more virtual contrast agents;
modeling, using a processor, an injection of the one or more virtual contrast agents into the anatomic model using the two-phase system;
determining a second point of interest downstream of the location associated with the narrowing of the patient's vasculature;
computing, based on the modeling, a value of concentration of the one or more virtual contrast agents at the determined second point of interest; and
determining one or more diagnostic flow metrics by comparing the received value of concentration at the determined first point of interest to the computed value of concentration at the determined second point of interest.
10. The system of claim 9 , wherein the one or more diagnostic flow metrics include a transluminal attenuation gradient, a corrected coronary opacification, a corrected thrombolysis in myocardial infarction frame count, a thrombolysis in myocardial infarction myocardial perfusion grade, or a combination thereof.
11. The system of claim 9 , wherein the at least one computer system is further configured for:
determining a threshold score, wherein the threshold score is associated with a risk of disease; and
comparing the one or more determined diagnostic flow metrics against the threshold score.
12. The system of claim 11 , wherein the at least one computer system is further configured for:
outputting a diagnosis for the disease, a diagnosis probability for the disease, or a combination thereof based on the comparison.
13. The system of claim 11 , wherein the at least one computer system is further configured for:
determining a primary metric of a blood flow characteristic; and
outputting a diagnosis for the disease, a diagnosis probability for the disease, or a combination thereof based on the primary metric and the comparison.
14. The system of claim 13 , wherein the primary metric is fractional flow reserve.
15. The system of claim 9 , wherein the at least one computer system is further configured for:
identifying one or more segments of the anatomic model, wherein each of the one or more determined diagnostic flow metrics are respective of one of the one or more segments.
16. The system of claim 9 , wherein the one or more determined diagnostic flow metrics are representative of a functional significance of stenoses in blood vessels.
17. A non-transitory computer readable medium for use on a computer system containing computer-executable programming instructions for assessing a risk of disease, the programming instructions, when executed by the computer system, performing a method comprising:
obtaining an anatomic model of a patient's vasculature;
determining a location of the anatomic model associated with a narrowing of the patient's vasculature;
determining a first point of interest upstream of the location associated with the narrowing of the patient's vasculature;
receiving a value of concentration of one or more virtual contrast agents at the determined first point of interest;
determining a density of the patient's blood and a density of the one or more virtual contrast agents;
determining a two-phase system for modeling the flow of the one or more virtual contrast agents and the patient's blood using the determined density of the patient's blood and determined density of the one or more virtual contrast agents;
modeling, using a processor, an injection of the one or more virtual contrast agents into the anatomic model using the two-phase system;
determining a second point of interest downstream of the location associated with the narrowing of the patient's vasculature;
computing, based on the modeling, a value of concentration of the one or more virtual contrast agents at the determined second point of interest; and
determining one or more diagnostic flow metrics by comparing the received value of concentration at the determined first point of interest to the computed value of concentration at the determined second point of interest.
18. The non-transitory computer readable medium of claim 17 , wherein the one or more diagnostic flow metrics include a transluminal attenuation gradient, a corrected coronary opacification, a corrected thrombolysis in myocardial infarction frame count, a thrombolysis in myocardial infarction myocardial perfusion grade, or a combination thereof.
19. The non-transitory computer readable medium of claim 17 , the method further comprising:
determining a threshold score, wherein the threshold score is associated with a risk of disease; and
comparing the one or more determined diagnostic flow metrics against the threshold score.
20. The non-transitory computer readable medium of claim 19 , the method further comprising:
outputting a diagnosis for the disease, a diagnosis probability for the disease, or a combination thereof based on the comparison.